3Mulhall JP. Subjective and objective analysis of the prevalence of Peyronie's disease in a population of men presenting for prostate cancer screeningEJ]. J Urol, 2004,171 : 2350.
4Gholami SS. Peyronie' s disease: a review[J]. J Urol, 2002,169 : 1234.
5Brant WO, Dean RC, Lue TF. Treatment of Peyronie's disease with oral pentoxifylline [J]. Nature Clin Pract Urol,2006,3:111.
6Bjekic MD, Vlajinae HD, Sipetic SB, et al.. Risk factors for Peyronie's disease: a case-control study[J]. BJU Int, 2006,97(3) : 570.
9Di Stasi SM, Giannantoni A, Stephen RL, et al. A prospective, randomized study using transdermal electromotive administration of verapamil and dexamethasone for Peyronie's disease[J]. J Urol, 2004,171 (4) : 1605.
10Altar H, Syed H, Abbasi TB, et al. Nesbit procedure for disabling Peyronier's curvature: a median follow - up of 84 months[J]. Urology,2003,61(5) : 1001.
二级参考文献13
1Deveci S, Palese M, Parker M, et al. Erectile function profiles in men with Peyronie's disease. J Urol, 2006, 175 (5) : 1807- 1811.
2Hauck EW, Hauptmann A, Haag SM, et al. New insights into the etiological pathogenesis of peyronie's disease. Aktuelle Urol, 2003, 34(6) :387-391.
3Levine LA, Estrada CR, Storm DW, et al. Peyronie disease in younger men: characteristics and treatment results. J Androl, 2003, 24( 1 ) :27-32.
4Schwarzer U, Sommer F, Klotz T, et al. The prevalence of Peyronie's disease: results of a large survey. BJU Int, 2001, 88 (7) : 727-730.
5Gelbard MK, Dorey F, James K. The natural history of Peyronieg disease. J Urol, 1990, 144(6): 1376-1379.
6Pryor J, Akkus E, Alter G, et al. Peyronie's disease. J Sex Med, 2004, 1(1) :110-115.
7Kadioglu A, Sanli O, Akman T, et al. Graft materials in Peyronie's disease surgery: a comprehensive review. J Sex Med, 2007, 4(3) :581-595.
8Shioshvili TJ, Kakonashvili AP. The surgical treatment of Peyronie's disease : replacement of plaque by free autograft of buccal mucosa. Eur Urol, 2005, 48( 1 ) :129-135.
9Dublin N, Stewart LH. Oral comphcations after buccal mucosal graft harvest for urethroplasty. BJU Int, 2004, 94(6) :867-869.
4Nickel P,Bold G,Presber F,et al.High levels of CMV-IE-I-specific memory tcells are associated with less alloimmunityand improved renal allograft function[J].Transpl Immunol,2009,20(4):238.
5Brock G, Hsu GL, Nunes L, et al. The anatomy of the tunica albug- inea in the normal penis and Peyronie's disease[J]. J Urol, 1997, 157(1):276 -281.
6Lischer GH, Nehra A. New advances in Peyronie's disease[J]. Curr Opin Urol, 2001,11 (6) : 631 - 636.
7Hauck EW, Hauptmann A, Haag SM, et al. New Insights into the Etiological Pathogenesis of Peyronie's Disease [ J ]. Aktuelle Urol, 2003,34(6) :387 - 391.
8Carrieri MP, Serraino D, Palmiotto F, et al. A case - control study on risk factors for Peyronie's disease[J]. J Clin Epidemiol, 1998, 51(6):511 -515.
